COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,844 Articles (22,553 medRxiv, 8,291 bioRxiv)

Most recent first Previous |  Page 2126: Articles 21251-21260  | Next

Funding and COVID-19 Research Priorities - Are the research needs for Africa being met?
Antonio, E., Alobo, M., Tufet-Bayona, M., Marsh, K., Norton, A.
10.1101/2020.10.12.20211565 — Posted: 2020-10-14
Automated chest radiograph diagnosis: A Twofer for tuberculosis and Covid-19
Verma, M., Patkar, D., Ingalhalikar, M., Kharat, A., Ajmera, P., Kulkarni, V., Pant, A., Thakker, V., Naik, G.
10.1101/2020.10.13.20178483 — Posted: 2020-10-14
Use of antivirals and antibiotics for COVID-19 in Mexico City: A Real-World Multicenter Cohort Study
Mancilla-Galindo, J., Garcia-Mendez, J. O., Marquez-Sanchez, J., Reyes-Casarrubias, R. E., Aguirre-Aguilar, E., Rocha-Gonzalez, H. I., Kammar-Garcia, A.
10.1101/2020.10.13.20211797 — Posted: 2020-10-14
How Policies on Restaurants, Bars, Nightclubs, Masks, Schools, and Travel Influenced Swiss COVID-19 Reproduction Ratios
Sruthi, C. K., Biswal, M. R., Joshi, H., Saraswat, B., Prakash, M. K.
10.1101/2020.10.11.20210641 — Posted: 2020-10-14
Rapid detection of SARS-CoV-2 antibodies in oral fluids
MacMullan, M. A., Chellamuthu, P., Mades, A., Das, S., Turner, F., Slepnev, V. I., Ibrayeva, A.
10.1101/2020.10.12.20210609 — Posted: 2020-10-14
Using Automated-Machine Learning to Predict COVID-19 Patient Survival: Identify Influential Biomarkers
Ikemura, K., Goldstein, D. Y., Szymanski, J., Bellin, E., Stahl, L., Yagi, Y., Saada, M., Simone, K., Reyes Gil, M.
10.1101/2020.10.12.20211086 — Posted: 2020-10-14 Discussion: Onsite
News Coverage and Drug Shortages during the COVID-19 Pandemic
Catillon, M., Majumder, M. S., Manzi, S. F., Mandl, K. D.
10.1101/2020.10.12.20211656 — Posted: 2020-10-14
Early Crowdfunding Response to the COVID-19 Pandemic
Saleh, S. N., Lehmann, C. U., Medford, R. J.
10.1101/2020.10.12.20211532 — Posted: 2020-10-14
SARS-CoV-2 sequencing reveals rapid transmission from college student clusters resulting in morbidity and deaths in vulnerable populations
Richmond, C. S., Sabin, A. P., Jobe, D. A., Lovrich, S. D., Kenny, P. A.
10.1101/2020.10.12.20210294 — Posted: 2020-10-14 Discussion: Onsite | Offsite
COVID-19 in Italy: targeted testing as a proxy of limited health care facilities and a key to reducing hospitalization rate and the death toll.
Bandyopadhyay, A., Schips, M., Mitra, T., Khailaie, S., Binder, S., Meyer-Hermann, M.
10.1101/2020.10.12.20211169 — Posted: 2020-10-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).